AAPL
49
-3
APD
45
-4
AKAM
42
2
AIZ
76
-2
AEE
64
-2
ADBE
47
2
BAC
62
3
BIIB
51
-5
AXP
62
2
AVGO
35
-3
AIV
47
10
APA
48
-2
AMAT
43
11
ABT
47
-3
AVY
37
-4
BAX
38
-3
ALL
66
13
AEP
64
-3
AMGN
25
-5
APH
59
3
AAPL
49
-3
APD
45
-4
AKAM
42
2
AIZ
76
-2
AEE
64
-2
ADBE
47
2
BAC
62
3
BIIB
51
-5
AXP
62
2
AVGO
35
-3
AIV
47
10
APA
48
-2
AMAT
43
11
ABT
47
-3
AVY
37
-4
BAX
38
-3
ALL
66
13
AEP
64
-3
AMGN
25
-5
APH
59
3
Financhill
Back

Accenture plc - Ordinary Shares - Class A Vs. Keros Therapeutics Industry Stock Comparison

Sell
42

ACN
Accenture plc - Ordinary Shares - Class A

Last Price:
$254.27
Seasonality Move:
4.52%
Sell
27

KROS
Keros Therapeutics

Last Price:
$14.42
Seasonality Move:
36.05%
Sell
42
Accenture plc - Ordinary Shares - Class A (ACN) is a Sell

Is Accenture plc - Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Accenture plc - Ordinary Shares - Class A [ACN] share price is $249.13. The Score for ACN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $14.48. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACN Stock Price Chart

What is Accenture plc - Ordinary Shares - Class A's stock price today?

  • The Accenture plc - Ordinary Shares - Class A share price today is $249.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACN is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $14.48
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.

ACN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.89 Sell
Relative Strength Index (14 RSI): 35.48 Sell
Chaikin Money Flow: 1395707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (245.94 - 281.44) Sell
Bollinger Bands (100): (271.31 - 316.13) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.43 Buy
Relative Strength Index (14 RSI): 55.85 Buy
Chaikin Money Flow: 287809 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ACN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 243.17 Buy
20-day SMA: 259.45 Sell
50-day SMA: 283.12 Sell
200-day SMA: 325.33 Sell
8-day EMA: 247.19 Buy
20-day EMA: 257.15 Sell
50-day EMA: 276.12 Sell
200-day EMA: 310.67 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.93 Buy
20-day SMA: 14.17 Buy
50-day SMA: 14 Buy
200-day SMA: 20.92 Sell
8-day EMA: 13.69 Buy
20-day EMA: 10.63 Buy
50-day EMA: 6.06 Buy
200-day EMA: 1.85 Buy

Accenture plc - Ordinary Shares - Class A Earnings Growth & ACN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.04 per share, an increase this year of $0.97 per share, and an increase next year of $0.95 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.57 per share, an increase this year of $5.09 per share, and a decrease next year of $4.95 per share.

Accenture plc - Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):